Manuel Reina
Corporate Officer/Principal chez University of Barcelona
Profil
Manuel Reina is a Director of Advanced In Vitro Cell Technologies SL.
He is an Associate Professor of Cell Biology at the University of Barcelona.
He is a Co-Director of Celltec UB and a Member of the Origami Society.
Dr. Reina received a PhD in Molecular Biology from CSIC, Barcelona.
Postes actifs de Manuel Reina
| Sociétés | Poste | Début |
|---|---|---|
| University of Barcelona | Corporate Officer/Principal | - |
Anciens postes connus de Manuel Reina
| Sociétés | Poste | Fin |
|---|---|---|
Advancell Advanced In Vitro Cell Technologies SL
 Advancell Advanced In Vitro Cell Technologies SL BiotechnologyHealth Technology Advancell Advanced In Vitro Cell Technologies SL is a holding company engaged in the design, development, and testing of pharmaceutical products. It focuses on indications in the areas of oncology, dermatology, and neurology. Its pipeline consists of medications for hand-food syndrome, chronic lymphocytic leukemia, multiple sclerosis, psoriasis, and myelodysplastic syndromes. These are then licensed to affiliates for manufacturing and distribution. The company was founded by Susana Castel-Gil, Senen Vilar, and Manuel Reina in 2001, and is headquartered in Barcelona, Spain. | Directeur/Membre du Conseil | - |
Formation de Manuel Reina
| Consejo Superior de Investigaciones Científicas | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Advancell Advanced In Vitro Cell Technologies SL
Advancell Advanced In Vitro Cell Technologies SL BiotechnologyHealth Technology Advancell Advanced In Vitro Cell Technologies SL is a holding company engaged in the design, development, and testing of pharmaceutical products. It focuses on indications in the areas of oncology, dermatology, and neurology. Its pipeline consists of medications for hand-food syndrome, chronic lymphocytic leukemia, multiple sclerosis, psoriasis, and myelodysplastic syndromes. These are then licensed to affiliates for manufacturing and distribution. The company was founded by Susana Castel-Gil, Senen Vilar, and Manuel Reina in 2001, and is headquartered in Barcelona, Spain. | Health Technology |